France has canceled its order for Merck’s new Covid-19 antiviral treatment molnupiravir due to its weak performance in trials, and ordered Pfizer’s Paxlovid instead, Health Minister Olivier Veran said on Wednesday.
“With molnupiravir, we had to cancel the order,” Veran told BFMTV, explaining that the latest trial results of Merck’s treatment were “not good.” The cancellation of the 50,000 doses of the drug has incurred no costs to France, he stressed.
Instead of Merck’s pills, France has ordered a competing treatment, Pfizer’s Paxlovid, which Veran described as “extremely promising” in reducing the risk of developing serious forms of Covid-19. The minister said that the drug, which is awaiting approval by the European Medicines Agency, would become available by the end of January.
He did not specify how many doses of Paxlovid had been ordered.
Merck earlier reported that its pills reduced the risk of hospitalization and deaths by 30%, which is significantly less impressive than the 89% reduction reported by Pfizer.
France is the first country to announce cancellation of its Merck order. The UK and German governments are among those that have already bought doses of the drug.
source: RT
Împotriva articolelor redacției noastre, persoanele nemulțumite pot formula Contestație în termen de 10 zile de la publicarea articolului, la judecătoria Orășenească nr. 1 München Bayern Deutschland, in conformitate cu Legea federală Germană. Considerăm că nu se pot formula acțiuni la instanțele din România deoarece nici o persoană care activează în trustul nostru nu poate fi extrasă de sub jurisdicția federală germană. Considerăm că redacția noastră nu răspunde în fața autorităților din România ci doar celor federale sau civile germane. deoarece legea română nu are efecte de extraneitate asupra redacției chiar dacă subiectul știrilor face obiectul unor evenimente sau persoane din România și sunt scrise în limba română. Limba română nu este izvor de extraneitate a legii.
absolvent WEB DESIGN Academia Britanică de Comunicare Iasi - absolvent COMUNICARE IN AFACERI Academia Britanica de Afaceri si Comunicare -absolvent JURNALISM EDITORIAL - London School University - 2019 inscris la echivalare diploma la Universitatea Politehnica Timisoara - absolvent studii de Drept Universitatea Europeană Drăgan, cursuri in Drept la Universitatea de Vest Timisoara, absolvent studii de proiectare, pastor coordonator in Biserica Protestanta Evanghelica,
Android Developer pe Google Play și plugin developer la Oxwall, creator de teme Wordpress și Oxwall, operator Wordpress, Drupal, Oxwall, Osclass, Moodle, tehnologii HTML și PHP
South Korean minors aged 12-17 and expectant women will be included in the country’s inoculation drive, Seoul’s vaccination advisory committee has announced. Booster shots will also be available to its elderly citizens. On Monday, the Korea Disease Control and Prevention Agency (KDCA) unveiled its list of eligible recipients for Covid-19 vaccination in its bid to […]
The European Court of Justice has ruled that the EU may cut funding to member states that violate its ‘rule of law’ standards The EU’s top court has dismissed a complaint filed by Poland and Hungary against a mechanism allowing Brussels to punish member states it deems ‘rule-of-law violators.’ The so-called “conditionality mechanism” gives the […]
Berlin will launch a study to assess the reliability of rapid antigen tests Germany’s health minister has admitted that experts are unsure how reliable rapid antigen tests are given the emergence of the Omicron variant of Covid-19. He announced a study into the testing kits. Speaking to public broadcasting channel ARD on Sunday, Health Minister […]
